More articles from Drug therapies in

You have access
Drug therapies in chronic heart failure: a focus on reduced ejection fraction
Helena Bolam, Geraint Morton and Paul R Kalra

Clin Med April 2018, DOI: https://doi.org/10.7861/clinmedicine.18-2-138
You have access
Developments in therapy with monoclonal antibodies and related proteins
H Michael Shepard, Gail Lewis Phillips, Christopher D Thanos and Marc Feldmann

Clin Med June 2017, DOI: https://doi.org/10.7861/clinmedicine.17-3-220
You have access
Drug therapy in anticoagulation: which drug for which patient?
Carolyn M Millar and Mike A Laffan

Clin Med June 2017, DOI: https://doi.org/10.7861/clinmedicine.17-3-233
You have access
Drugs for hypercholesterolaemia – from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition
Anthony S Wierzbicki and Paul Grant

Clin Med August 2016, DOI: https://doi.org/10.7861/clinmedicine.16-4-353
You have access
The newer direct oral anticoagulants: a practical guide
Jecko Thachil

Clin Med April 2014, DOI: https://doi.org/10.7861/clinmedicine.14-2-165
You have access
Drug therapies in dermatology
Arif Aslam and Christopher EM Griffiths

Clin Med February 2014, DOI: https://doi.org/10.7861/clinmedicine.14-1-47
You have access
Recent changes in the drug treatment of allergic asthma
David Gibeon and Andrew Menzies-Gow

Clin Med October 2013, DOI: https://doi.org/10.7861/clinmedicine.13-5-477

Main menu